A Snapshot of the Response from UK-based Clinical Trials of Investigational Medicinal Products to COVID-19

Background/Aims Coronavirus Disease 2019 (COVID-19) has presented an unprecedented challenge for non-COVID related clinical trials of investigational medicinal medicines (CTIMPs). These challenges are considerable for trials run in high -risk groups, such as older adults. Clinical trials must ensure...

Descripción completa

Detalles Bibliográficos
Autores principales: Neumann, Sandra, Henderson, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584312/
https://www.ncbi.nlm.nih.gov/pubmed/33123427
http://dx.doi.org/10.7759/cureus.10613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584312/
https://www.ncbi.nlm.nih.gov/pubmed/33123427
http://dx.doi.org/10.7759/cureus.10613

Ejemplares similares